AMH producing purely cystic virilizing adult granulosa cell tumor in 17 years old girl: a case report and review of literatures

Granulosa cell tumor (GCT) is the most common type of sex cord stromal tumor of the ovary. Due to its ability of hormone production, most of the cases (97–98%) may show hyperestrogenism, such as amenorrhea, dysfunctional menstrual bleeding, growth of uterine leiomyomas, hyperplasia of the endometrium, or endometrial cancer. In rare circumstances, androgen producing GCTs may be present (2–3%). The symptoms and signs of the virilizing GCTs are primary or secondary amenorrhea, hirsutism, clitoromegaly, deepening of the voice, muscular development and acne due to elevated testosterone levels [12]. In our case, apparent hyperandrogenism was present and they were disappeared after removal of cystic mass of left ovary.

Among the case reports of androgen producing GCTs, the degree of virilization and clinicopathological findings showed wide range of variations [4,5,6,7,8,9,10,11,12,13,14,15,16]. In the report of large series of virilizing GCTs, although the solid tumor is more common in GCTs, seven tumors among 17 cases were cystic, of which five with unilocular and two cases presented multilocular cystic tumor. In these seven cases, six tumors were diagnosed as adult type GCT [10]. On the other hand, androgenic juvenile type GCT with unilocular cystic presentation in 13 years old girl was also reported [11].

As GCTs are generally described as unilateral solid masses with a variable amount of cystic component, purely cystic granulosa cell tumor is rare condition. Mulvany and Riley reported six cases of cystic granulosa cell tumor, they are all larger than 10 cm and adult type, which is concord with present case [20]. In some case with virilizing GCTs, cystic form without apparent solid potion had been reported [10]. Although it is rare, estrogen producing cystic GCT in 18 years old girl that histopathologically diagnosed as jeuvinile type CGT was reported [21]. Recently, Boyraz B, et al., reported large case series of cystic GCTs [17]. They found a tendency for cystic adult GCTs to occur in younger patients than its typical counterpart, and 25% of them exhibited androgenic manifestations. In addition, cystic juvenile GCTs are more often androgenic than the prior literature has indicated (52% in their report). They also pointed out that adult or juvenile GCTs that are strikingly cystic, and extensive denudation of cyst linings in cystic GCTs often cause a diagnostic challenge. They also discussed multicystic formation of adjacent part of the lesion may be hormonally driven rather than neoplastic in nature. The possible association between cyst formation, stromal luteinization, and subsequent androgenic manifestations may be presented.

FOXL2, Forkhead box L2, belongs to the large family of forkhead/winged-helix transcription factors, and its mutation is reported to be involved in the development of adult GCTs [22]. Therefore, detection of the expression of FOXL2 in GCTs can be helpful in the diagnosis of GCTs [23]. In present case, we could not explore FOXL2 mutations due to the limited amount of cellular portion. The usefulness of FOXL2 examination in the diagnosis of androgenic cystic GCTs may need further investigations.

Since there is non-specific image study and difficulty in histological determination of purely cystic androgenic GCTs, other diagnostic measures may be desirable. AMH is a dimeric glycoprotein that is secreted solely by ovarian granulosa cells in women [18]. Studies suggested AMH may be a marker of tumor recurrence, progression, and treatment efficacy in adult type GCT [24, 25]. Reliable correlation between serum AMH levels and tumor mass that determined by pathological specimens or imaging measures had been reported [26]. Recent meta-analysis concluded that serum AMH can diagnose GCT with high accuracy (sensitivity:0.89 and specificity:0.93) [19]. In our case, serum AMH is markedly elevated and decreased to normal levels and maintained low after surgery without any signs of recurrence. As the adult-subtype representing 95% of all GCTs, occurs in perimenopausal or postmenopausal women, at a peak age frequency between 50 and 55 years, which age may show undetectable serum AMH without tumor, AMH may possess ideal diagnostic role. On the other hand, adolescent like our case may show high AMH levels, especially case with ovulatory dysfunction, which may limit the efficacy of serum AMH levels as a diagnosis measure. However, serum AMH levels found in women with GCTs may show well above those of women with ovulatory dysfunction even in women with cystic GCTs like our case. The role of AMH as a marker of cystic androgenic GCTs may need further investigation.

Our presented case showed hormonal profiles corresponding to hyperandrogenism and amenorrhea. Elevated testosterone and AMH may be produced from the tumor. These hormones may influence the status of contralateral ovary. In our case, contralateral ovary showed polycystic appearance. It is well known that PCOS is manifested by elevated testosterone, LH, and AMH. Elevated testosterone may stimulate LH secretions, which may stimulate theca cell activity in contralateral ovary and results in arrest of follicular growth and additional secretion of testosterone and AMH from contralateral ovary. These vicious cycles may affect morphology of contralateral ovary and acute hyperandrogenism in present case. The surgical removal of the tumor normalized hormonal profiles. On the other hand, androgen producing GCTs complicated with PCOS had been reported [4,5,6]. Clinical signs of PCOS may be overlapped with those of androgen producing GCTs, though apparent virilization found in GCTs may be less frequent in PCOS. In reported case, the symptom related to PCOS have not improved after the cystectomy [5]. Persistence of androgenic symptom after the surgery also reported by the others [15]. Considering the experience with our case and other reported cases, androgenic GCTs may stimulate latent PCOS status in affected women. Postsurgical follow up of ovulatory status together with morphological appearance of contralateral ovary may be recommended.

The mechanism of androgen dominant secretion by cystic GCTs are not fully understood. Altered expression of steroid synthesis enzymes may be one of the possible mechanisms. P450 aromatase is a key enzyme to convert androstenedione to estrone and estradiol. Immunohistochemical expression of P450 aromatase were confirmed in estrogen producing GCTs [27]. The expression of P450 aromatase corresponds to specific cell morphology of GCTs, including recurrent tumors [28]. A deficiency of aromatase may suppress the conversion of androgen to estrogen, thus triggering excessive androgen accumulation. On the other hand, elevated AMH produced by GCTs may be another mechanism for elevated androgen in this case. Excess AMH may trigger an imbalance in the hypothalamic–pituitary–ovarian axis, subsequently inducing elevated LH levels and hyperandrogenism via binding to the AMH receptors of GnRH neurons [29]. However, the elevation of testosterone and LH can be affected by multiple pathways; therefore, the definite mechanism may need more studies.

In conclusion, cystic virilizing GCTs are rare causes of hyperandrogenism in adolescents. A definitive diagnosis by histopathology may be difficult due to denudation of cellular lining of cyst wall. Markedly elevated serum AMH levels may be useful for diagnosis. Elevated testosterone and AMH may affect contralateral ovarian status. Latent ovulatory dysfunctions may be modified by hormones secreted by the tumor. The cyst may be treated surgically; most of the cases are discovered at an early stage; without a need for postoperative adjuvant therapy; however, long-term follow up should be considered.

留言 (0)

沒有登入
gif